NuCana (NCNA) Cash & Equivalents (2016 - 2025)

NuCana has disclosed Cash & Equivalents across 10 years of filings, most recently posting $9.0 million for Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $9.0 million, up 3.64% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.0 million (up 3.64% YoY), and the FY2025 annual result was $8.9 million, up 3.15% from the prior year.
• Cash & Equivalents came in at $9.0 million for Q4 2025 at NuCana, down from $9.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $122.1 million in Q2 2021 to a low of $5.0 million in Q1 2025.
• The 5-year median for Cash & Equivalents is $50.1 million (2022), against an average of $48.3 million.
• Across the five-year window, Cash & Equivalents jumped 89.24% in 2021 and tumbled 69.5% in 2025, its largest moves.
• NuCana's Cash & Equivalents stood at $81.2 million in 2021, then slumped by 39.49% to $49.2 million in 2022, then tumbled by 56.51% to $21.4 million in 2023, then tumbled by 59.48% to $8.7 million in 2024, then gained by 3.64% to $9.0 million in 2025.
• The last three Cash & Equivalents figures came in at $9.0 million (Q4 2025), $9.1 million (Q3 2025), and $9.0 million (Q2 2025), per Business Quant data.